Riskpilot← Back to searchSign inGet full accessNaprapathälsan i Sollentuna AB
ABActiveOrg 5568251101Turebergsleden 105Physiotherapy activities · NACE 8695Est. 20105-9 employees
Revenue 2024
SEK 3,9M
-4% vs 2023
EBITDA margin
-2.5%
-171% vs 2023
Equity ratio
31.2%
Financial strength
Net profit 2024
SEK -25K
-125% vs 2023
| Revenue | SEK 3,9M | -4% |
| EBITDA | SEK -100K | -171% |
| Net profit | SEK -25K | -125% |
| Total assets | SEK 972K | -18% |
| Equity | SEK 303K | -29% |
| Employees | — | — |
Legal name
Naprapathälsan i Sollentuna AB
Org number
5568251101
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
13 november 2010
Share capital
SEK 50 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva naprapatverksamhet och därmed förenlig verksamhet.
Address
Turebergsleden 105
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 329 | 3 792 | 3 705 | 4 057 | 3 915 |
| Staff expenses | — | — | −2 599 | −2 621 | −2 708 |
| EBITDA | 540 | 170 | 59 | 141 | −100 |
| Depreciation & amort. | −30 | −4 | −19 | −15 | −15 |
| EBIT | 510 | 166 | 40 | 126 | −115 |
| Net financials | — | — | −0 | 4 | 6 |
| Profit before tax | 380 | 166 | 40 | 130 | −25 |
| Tax | −83 | −36 | −13 | −29 | — |
| Net profit | 297 | 130 | 27 | 101 | −25 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 102 | 1 050 | 997 | 1 185 | 972 |
| Equity | 569 | 500 | 427 | 428 | 303 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 403 | 421 | 441 | 627 | 623 |
| Total debt | 403 | 421 | 441 | 627 | 623 |
EBITDA margin
-2.5%
This company
15.8%
Market median
-116% vs market
20202024
Equity ratio
31.2%
This company
38.2%
Market median
+18% vs market
20202024
Return on equity
-8.2%
This company
18.4%
Market median
-145% vs market
20202024
Net profit margin
-0.6%
This company
8.1%
Market median
-107% vs market
20202024
Asset turnover
4.03×
This company
1.12×
Market median
+260% vs market
20202024
Debt / equity
2.21×
This company
0.62×
Market median
-256% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
SJ Audit | Audit | 2025 |
AK Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Naprapathälsan i Sollentuna AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stig Johan Rendert | Audit | 0 companies |
| Anna Katarina Zae Eun Gunnarsson | Chief Executive Officer | 0 companies |
| Per Morgan Gunnarsson | Deputy Board Member | 0 companies |
| Marie Josefine Nyström | Chairman | 0 companies |
| Mattias Nyström | Deputy Board Member | 0 companies |